title: Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant.
authors.affiliation: Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania.
authors.forename: A B
authors.initials: AB
authors.lastname: Jain
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: R
authors.initials: R
authors.lastname: Venkataramanan
authors.forename: R
authors.initials: R
authors.lastname: Day
authors.forename: J
authors.initials: J
authors.lastname: Bryant
authors.forename: K M
authors.initials: KM
authors.lastname: Abu-Elmagd
authors.forename: M
authors.initials: M
authors.lastname: Alessiani
authors.forename: S
authors.initials: S
authors.lastname: Takaya
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
mesh_terms: D000704:Analysis of Variance; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*
chemical_list: D011241:Prednisone; D016559:Tacrolimus